China Pharma Holdings (CPHI) Stock Statistics & Valuation Metrics

China Pharma Holdings has a market cap or net worth of $23.10M. The enterprise value is $6.00M.

China Pharma Holdings has 40,522,003 shares outstanding. The number of shares has decreased by -2.65% in one year.

China Pharma Holdings’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -11.28%.

The current PE Ratio of China Pharma Holdings is ―. China Pharma Holdings’s PEG ratio is -0.00939.

In the last 12 months, China Pharma Holdings had revenue of 4.14M and earned -3.19M in profits. Earnings per share was -0.74.

In the last 12 months, operating cash flow was 150.79K and capital expenditures -16.30K, giving a free cash flow of 134.49K billion.

China Pharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

China Pharma Holdings upcoming earnings date is May 15, 2025, Before Open (Confirmed).

China Pharma Holdings as a current ratio of 0.32, with Debt / Equity ratio of 9.57%

In the past 12 months, China Pharma Holdings has paid 0.00 in taxes.

China Pharma Holdings EV to EBITDA ratio is -5.80, with an EV/FCF ratio of 793.30.

China Pharma Holdings has $168.47K in cash and marketable securities with $3.86M in debt, giving a net cash position of -$3.69M billion.

Gross margin is -13.42%, with operating margin of -74.53%, and net profit margin of -76.91%.

The average price target for China Pharma Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―